Related Experiment Videos
Hyperphenylalaninemia in Polish children's population
Insights
Newborn screening identified 144 hyperphenylalaninemia cases. Most had phenylketonuria (PKU) requiring diet, while others had mild forms managed without treatment, showing normal development.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Hyperphenylalaninemia (HPA) is a metabolic disorder often detected via newborn screening.
- Early diagnosis and management are crucial for preventing intellectual disability.
Purpose of the Study:
- To discuss the differential diagnosis of HPA detected in newborns.
- To evaluate outcomes for infants diagnosed with phenylketonuria (PKU) and mild HPA.
Main Methods:
- Analysis of 144 newborn screening cases for HPA.
- Diagnostic confirmation using protein loading tests for doubtful cases.
- Longitudinal monitoring of biochemical markers and developmental scores.
Main Results:
- 123 infants were diagnosed with phenylketonuria (PKU) and initiated on a low-phenylalanine diet.
- 21 infants diagnosed with mild HPA showed decreasing phenylalanine and tyrosine levels with age.
- Overall normal mental development was observed in the mild HPA group by age 3-7 years.
Conclusions:
- Newborn screening effectively identifies HPA, enabling timely intervention for PKU.
- Mild HPA cases can be managed conservatively with regular monitoring.
- Further investigation is warranted for the two cases with lower IQs in the mild HPA group.
Abstract:
Differential diagnosis in 144 cases of hyperphenylalaninemia detected through the newborn screening is discussed. In 123 infants phenylketonuria was diagnosed, so they were treated with the low phe diet. Verificatory examinations performed in diagnostically doubtful cases with the use of protein loading confirmed persistent enzymatic defect in all of them. In 21 infants with blood serum phenylalanine level below 15 mg% and lack of phe urinary metabolites, preliminary diagnosis of mild hyperphenylalaninemia was made and they were left without dietary treatment. A decrease with age in phenylalanine and tyrosine values was observed in this group. Mental development score, in the group as a whole, at age 3-7 years was normal. Two cases with relatively low IQ values have been discussed in regard to possible reason of their mental delay.